Evidence-Based Medicine Guidelines
Beta-blockers for hyperthyreoidism
Beta-blockers for hyperthyreoidism is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Beta-blockers for Hyperthyreoidism." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism.
Beta-blockers for hyperthyreoidism. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism. Accessed March 30, 2023.
Beta-blockers for hyperthyreoidism. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism
Beta-blockers for Hyperthyreoidism [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beta-blockers for hyperthyreoidism
ID - 452585
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452585/all/Beta_blockers_for_hyperthyreoidism
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
